Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 123


Mining for pairs: shared clinic visit dates identify steady HIV-positive partnerships.

Marzel A, Shilaih M, Turk T, Campbell NK, Yang WL, Böni J, Yerly S, Klimkait T, Aubert V, Furrer H, Calmy A, Battegay M, Cavassini M, Bernasconi E, Schmid P, Metzner KJ, Günthard HF, Kouyos RD; Swiss HIV Cohort Study (SHCS).

HIV Med. 2017 Apr 4. doi: 10.1111/hiv.12507. [Epub ahead of print]


Cervical cancer screening in Switzerland: cross-sectional trends (1992-2012) in social inequalities.

Burton-Jeangros C, Cullati S, Manor O, Courvoisier DS, Bouchardy C, Guessous I.

Eur J Public Health. 2017 Feb 1;27(1):167-173. doi: 10.1093/eurpub/ckw113. No abstract available.



Burton-Jeangros C, Cullati S, Sacker A, Blane D.

In: Burton-Jeangros C, Cullati S, Sacker A, Blane D, editors. A Life Course Perspective on Health Trajectories and Transitions [Internet]. Cham (CH): Springer; 2015. Chapter 1.


Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs.

Oberle CS, Joos B, Rusert P, Campbell NK, Beauparlant D, Kuster H, Weber J, Schenkel CD, Scherrer AU, Magnus C, Kouyos R, Rieder P, Niederöst B, Braun DL, Pavlovic J, Böni J, Yerly S, Klimkait T, Aubert V, Trkola A, Metzner KJ, Günthard HF; Swiss HIV Cohort Study (SHCS).

Retrovirology. 2016 Sep 5;13(1):62. doi: 10.1186/s12977-016-0299-0.


Genotypic Resistance Tests Sequences Reveal the Role of Marginalized Populations in HIV-1 Transmission in Switzerland.

Shilaih M, Marzel A, Yang WL, Scherrer AU, Schüpbach J, Böni J, Yerly S, Hirsch HH, Aubert V, Cavassini M, Klimkait T, Vernazza PL, Bernasconi E, Furrer H, Günthard HF, Kouyos R; Swiss HIV Cohort Study.

Sci Rep. 2016 Jun 14;6:27580. doi: 10.1038/srep27580.


Dually Active HIV/HBV Antiretrovirals as Protection Against Incident Hepatitis B Infections: Potential for Prophylaxis.

Shilaih M, Marzel A, Scherrer AU, Braun DL, Kovari H, Rougemont M, Darling K, Battegay M, Hoffmann M, Bernasconi E, Hirzel C, Günthard HF, Kouyos RD; Swiss HIV Cohort Study a; Swiss HIV Cohort Study.

J Infect Dis. 2016 Aug 15;214(4):599-606. doi: 10.1093/infdis/jiw195. Epub 2016 May 18.


Successful Prevention of Transmission of Integrase Resistance in the Swiss HIV Cohort Study.

Scherrer AU, Yang WL, Kouyos RD, Böni J, Yerly S, Klimkait T, Aubert V, Cavassini M, Battegay M, Hauser C, Calmy A, Schmid P, Bernasconi E, Günthard HF; Swiss HIV Cohort Study.

J Infect Dis. 2016 Aug 1;214(3):399-402. doi: 10.1093/infdis/jiw165. Epub 2016 Apr 29.


Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals.

Barceló C, Gaspar F, Aouri M, Panchaud A, Rotger M, Guidi M, Cavassini M, Buclin T, Decosterd LA, Csajka C; Swiss HIV Cohort Study.

J Antimicrob Chemother. 2016 Jul;71(7):1933-42. doi: 10.1093/jac/dkw050. Epub 2016 Mar 29.


Correlating HIV tropism with immunological response under combination antiretroviral therapy.

Bader J, Schöni-Affolter F, Böni J, Gorgievski-Hrisoho M, Martinetti G, Battegay M, Klimkait T; Swiss HIV Cohort Study.

HIV Med. 2016 Sep;17(8):615-22. doi: 10.1111/hiv.12365. Epub 2016 Mar 17.


Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis.

Scherrer AU, von Wyl V, Yang WL, Kouyos RD, Böni J, Yerly S, Klimkait T, Aubert V, Cavassini M, Battegay M, Furrer H, Calmy A, Vernazza P, Bernasconi E, Günthard HF; and the Swiss HIV Cohort Study, Aubert V, Battegay M, Bernasconi E, Böni J, Braun DL, Bucher HC, Burton-Jeangros C, Calmy A, Cavassini M, Dollenmaier G, Egger M, Elzi L, Fehr J, Fellay J, Furrer H, Fux CA, Gorgievski M, Günthard H, Haerry D, Hasse B, Hirsch HH, Hoffmann M, Hösli I, Kahlert C, Kaiser L, Keiser O, Klimkait T, Kouyos R, Kovari H, Ledergerber B, Martinetti G, Martinez de Tejada B, Marzolini C, Metzner K, Müller N, Nadal D, Nicca D, Pantaleo G, Rauch A, Regenass S, Rudin C, Schöni-Affolter F, Schmid P, Speck R, Stöckle M, Tarr P, Trkola A, Vernazza P, Weber R, Yerly S.

Clin Infect Dis. 2016 May 15;62(10):1310-1317. doi: 10.1093/cid/ciw128. Epub 2016 Mar 8.


Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study.

Podlekareva DN, Efsen AM, Schultze A, Post FA, Skrahina AM, Panteleev A, Furrer H, Miller RF, Losso MH, Toibaro J, Miro JM, Vassilenko A, Girardi E, Bruyand M, Obel N, Lundgren JD, Mocroft A, Kirk O; TB:HIV study group in EuroCoord.

Lancet HIV. 2016 Mar;3(3):e120-31. doi: 10.1016/S2352-3018(15)00252-0. Epub 2016 Feb 2.


Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen.

De Luca A, Flandre P, Dunn D, Zazzi M, Wensing A, Santoro MM, Günthard HF, Wittkop L, Kordossis T, Garcia F, Castagna A, Cozzi-Lepri A, Churchill D, De Wit S, Brockmeyer NH, Imaz A, Mussini C, Obel N, Perno CF, Roca B, Reiss P, Schülter E, Torti C, van Sighem A, Zangerle R, Descamps D; CHAIN and COHERE in EuroCoord.

J Antimicrob Chemother. 2016 May;71(5):1352-60. doi: 10.1093/jac/dkv465. Epub 2016 Jan 28.


Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study.

Mocroft A, Lundgren JD, Ross M, Fux CA, Reiss P, Moranne O, Morlat P, Monforte Ad, Kirk O, Ryom L; Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) Study.

Lancet HIV. 2016 Jan;3(1):e23-32. doi: 10.1016/S2352-3018(15)00211-8. Epub 2015 Nov 17.


Marital breakup in later adulthood and self-rated health: a cross-sectional survey in Switzerland.

Knöpfli B, Cullati S, Courvoisier DS, Burton-Jeangros C, Perrig-Chiello P.

Int J Public Health. 2016 Apr;61(3):357-66. doi: 10.1007/s00038-015-0776-6. Epub 2016 Jan 5.


To what extent will women accept HPV self-sampling for cervical cancer screening? A qualitative study conducted in Switzerland.

Fargnoli V, Petignat P, Burton-Jeangros C.

Int J Womens Health. 2015 Nov 4;7:883-8. doi: 10.2147/IJWH.S90772. eCollection 2015.


Reasons for late presentation to HIV care in Switzerland.

Hachfeld A, Ledergerber B, Darling K, Weber R, Calmy A, Battegay M, Sugimoto K, Di Benedetto C, Fux CA, Tarr PE, Kouyos R, Furrer H, Wandeler G; Swiss HIV Cohort Study.

J Int AIDS Soc. 2015 Nov 18;18:20317. doi: 10.7448/IAS.18.1.20317. eCollection 2015.


Prostate cancer screening in Switzerland: 20-year trends and socioeconomic disparities.

Guessous I, Cullati S, Fedewa SA, Burton-Jeangros C, Courvoisier DS, Manor O, Bouchardy C.

Prev Med. 2016 Jan;82:83-91. doi: 10.1016/j.ypmed.2015.11.009. Epub 2015 Nov 12.


In Vivo Profiling and Distribution of Known and Novel Phase I and Phase II Metabolites of Efavirenz in Plasma, Urine, and Cerebrospinal Fluid.

Aouri M, Barcelo C, Ternon B, Cavassini M, Anagnostopoulos A, Yerly S, Hugues H, Vernazza P, Günthard HF, Buclin T, Telenti A, Rotger M, Decosterd LA; Swiss HIV Cohort Study.

Drug Metab Dispos. 2016 Jan;44(1):151-61. doi: 10.1124/dmd.115.065839. Epub 2015 Nov 9.


Frequency of and Risk Factors for Depression among Participants in the Swiss HIV Cohort Study (SHCS).

Anagnostopoulos A, Ledergerber B, Jaccard R, Shaw SA, Stoeckle M, Bernasconi E, Barth J, Calmy A, Berney A, Jenewein J, Weber R; Swiss HIV Cohort Study.

PLoS One. 2015 Oct 22;10(10):e0140943. doi: 10.1371/journal.pone.0140943. eCollection 2015.


The J-Curve in HIV: Low and Moderate Alcohol Intake Predicts Mortality but Not the Occurrence of Major Cardiovascular Events.

Wandeler G, Kraus D, Fehr J, Conen A, Calmy A, Orasch C, Battegay M, Schmid P, Bernasconi E, Furrer H; Swiss HIV Cohort Study.

J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):302-9. doi: 10.1097/QAI.0000000000000864.

Supplemental Content

Loading ...
Support Center